Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,433,955
+$7,379,559 QoQ
Shares Held
344,189
+153.1% QoQ
Ownership
0.225%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,607,351,941 across 214 Biotechnology names. TGTX ranks #30 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in TGTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,433,955 | 344,189 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $4,054,396 | 136,008 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,449,671 | 67,811 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,200,228 | 33,349 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,391,601 | 35,293 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,042,795 | 67,867 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,390,206 | 59,436 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $676,463 | 38,025 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $674,776 | 44,364 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $305,509 | 17,887 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $500,387 | 59,855 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,580,767 | 63,638 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $652,390 | 43,377 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $324,110 | 34,081 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $647,539 | 34,081 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,678,476 | 50,435 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,428,564 | 62,608 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,017,705 | 62,608 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,732,747 | 71,756 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,054,311 | 76,768 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,341,587 | 68,870 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $440,782 | 44,795 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||